Position in GLMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23
+$3 QoQ
Shares Held
43
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 13 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,528,481 across 417 Biotechnology names. GLMD ranks #399 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in GLMD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23 | 43 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $20 | 43 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $6 | 9 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $12 | 9 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $16 | 9 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12 | 9 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $57 | 18 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $123 | 18 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $56 | 204 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $70 | 204 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $92 | 204 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $126 | 204 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $609 | 204 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,302 | 3,050 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,525 | 3,050 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,259 | 4,050 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,114 | 6,330 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,064 | 6,330 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $11,520 | 6,330 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $17,660 | 6,330 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $19,243 | 6,330 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $21,711 | 6,330 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $19,686 | 6,330 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $22,344 | 6,330 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $30,257 | 6,330 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $21,901 | 6,330 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||